Atorvastatin

Chemical formula: C₃₃H₃₅FN₂O₅  Molecular mass: 558.64 g/mol  PubChem compound: 60823

Therapeutic indications

Atorvastatin is indicated for:

Cardiovascular event

Population group: only adults (18 years old or older)

Prevention of cardiovascular events in adult patients estimated to have a high risk for a first cardiovascular event, as an adjunct to correction of other risk factors.

To reduce the risk of:

  • Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD.
  • MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD.
  • Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Primary hypercholesterolaemia, combined hyperlipidaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Primary hypercholesterolemia
Mixed hyperlipidaemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Heterozygous familial hypercholesterolaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Familial hypercholesterolaemia - heterozygous

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Homozygous familial hypercholesterolaemia

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Familial hypercholesterolemia - homozygous

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Atorvastatin is contraindicated in the following cases:

Glecaprevir/pibrentasvir

at least one of
Glecaprevir and pibrentasvir
Glecaprevir
Pibrentasvir

Pregnancy

Pregnancy

Lactation

Lactation

Active liver disease, unexplained persistent elevations of serum transaminases

at least one of
Hepatopathy
Elevated liver enzymes level

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2022: LIPITOR Film-coated tablet
Summary of Product Characteristics (SPC) 2023: LIPITOR Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈